|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM370389816 |
003 |
DE-627 |
005 |
20240720232730.0 |
007 |
cr uuu---uuuuu |
008 |
240330s2024 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1002/adma.202401539
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1476.xml
|
035 |
|
|
|a (DE-627)NLM370389816
|
035 |
|
|
|a (NLM)38549454
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Xiao, Wuyi
|e verfasserin
|4 aut
|
245 |
1 |
2 |
|a A Viscous-Biofluid Self-Pumping Organohydrogel Dressing to Accelerate Diabetic Wound Healing
|
264 |
|
1 |
|c 2024
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 20.06.2024
|
500 |
|
|
|a Date Revised 20.07.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a © 2024 Wiley‐VCH GmbH.
|
520 |
|
|
|a Viscous biofluids on wounds challenge conventional "water-absorbing" wound dressings in efficient drainage due to their poor fluidity, generally causing prolonged inflammation, anti-angiogenesis, and delayed wound closure. Herein, it is reported that a self-pumping organohydrogel dressing (SPD) with aligned hydrated hydrogel channels, prepared by a three-dimensional-templated wetting-enabled-transfer (3D-WET) polymerization process, can efficiently drain viscous fluids and accelerate diabetic wound healing. The asymmetric wettability of the hydrophobic-hydrophilic layers and aligned hydrated hydrogel channels enable unidirectional and efficient drainage of viscous fluids away from the wounds, preventing their overhydration and inflammatory stimulation. The organogel layer can adhere onto the skin around the wounds but can be easily detached from the wet wound area, avoiding secondary trauma to the newly formed tissues. Taking a diabetic rat model as an example, the SPD can significantly downregulate the inflammation response by ≈70.8%, enhance the dermal remodeling by ≈14.3%, and shorten wound closure time by about 1/3 compared with the commercial dressing (3M, Tegaderm hydrocolloid thin dressing). This study sheds light on the development of the next generation of functional dressings for chronic wounds involving viscous biofluids
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a WET strategy
|
650 |
|
4 |
|a diabetic wound
|
650 |
|
4 |
|a organohydrogel
|
650 |
|
4 |
|a self‐pumping
|
650 |
|
4 |
|a viscous biofluids
|
650 |
|
7 |
|a Hydrogels
|2 NLM
|
700 |
1 |
|
|a Wan, Xizi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Shi, Lianxin
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ye, Maosheng
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zhang, Yikai
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wang, Shutao
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 36(2024), 25 vom: 26. Juni, Seite e2401539
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
773 |
1 |
8 |
|g volume:36
|g year:2024
|g number:25
|g day:26
|g month:06
|g pages:e2401539
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202401539
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 36
|j 2024
|e 25
|b 26
|c 06
|h e2401539
|